Summary & Overview

HCPCS Level II J0834: Cosyntropin 0.25 mg Injection

HCPCS Level II code J0834 denotes a 0.25 mg injection of cosyntropin used primarily for diagnostic adrenal stimulation testing. The code captures administration of a pharmacologic agent that aids in diagnosing adrenal insufficiency and related endocrine disorders. Nationally, accurate coding of J0834 matters for appropriate clinical documentation, claims processing, and consistency in reporting diagnostic endocrine procedures.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of billing and clinical context for J0834, including benchmarks where available, payer coverage patterns, common billing modifiers, and operational considerations for sites that commonly administer diagnostic injections. The publication highlights policy-relevant items such as coverage clarification and coding guidance rather than clinical guidance.

This summary is intended for revenue cycle professionals, clinical staff involved in endocrine testing, and policy analysts seeking a national perspective on how J0834 is used and reimbursed across major payers. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0834HCPCS Level IICosyntropinDiagnostic injectionEndocrine testingAdrenal insufficiencyOutpatient servicesMedical billing

Billing Code Overview

HCPCS Level II code J0834 represents an injection of cosyntropin, 0.25 mg. This product is used for diagnostic testing of adrenal insufficiency and stimulation testing of the hypothalamic-pituitary-adrenal axis.

Service type: Diagnostic injection
Typical site of service: Outpatient clinic, hospital outpatient department, or clinical laboratory setting where endocrine diagnostic testing is performed.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult presenting to an outpatient infusion clinic or emergency department for evaluation of suspected adrenal insufficiency or for assessment of hypothalamic-pituitary-adrenal (HPA) axis function. The patient frequently has symptoms such as unexplained fatigue, hypotension, weight loss, abdominal pain, or orthostatic dizziness, or there is concern for secondary adrenal insufficiency after pituitary surgery or prolonged steroid taper. The ordered diagnostic test is an ACTH stimulation test using J0834 (cosyntropin, 0.25 mg) administered intramuscularly or intravenously.

The clinical workflow: the clinician documents indications and obtains informed consent; baseline vital signs and baseline serum cortisol (and sometimes plasma ACTH) are drawn; a nurse or licensed professional administers J0834 per protocol (commonly 250 mcg cosyntropin IV/IM); timed post‑dose cortisol samples are obtained (commonly at 30 and 60 minutes); samples are sent to the lab and results are interpreted by the ordering clinician to confirm or exclude adrenal insufficiency. Billing for J0834 is reported for the cosyntropin drug administered; separate billing may occur for laboratory assays, venipuncture, and evaluation and management services as clinically appropriate.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — standard billing	Use when no special modifier applies to the service.
`23`	Unusual anesthesia — not typically for this drug but present in list	Use if unusual anesthesia circumstances are reported concurrently (rare for cosyntropin).
`25`	Significant, separately identifiable E/M service	Use when a distinct evaluation and management visit is provided on the same day as the injection.
`52`	Reduced services	Use when the cosyntropin dose or service is partially reduced from the usual protocol.
`53`	Discontinued procedure	Use if the test is started but discontinued for patient safety before full administration.
`59`	Distinct procedural service	Use to indicate a distinct procedure unrelated to other services billed on the same day.
`62`	Two surgeons	Use when two surgeons are involved in a concurrent surgical procedure (rare for this test).
`78`	Return to OR for related procedure during postoperative period	Use only if patient requires a return to operating room for related surgical issue.
`80`	Assistant at surgery	Use when a surgical assistant participates in a related operative procedure.
`82`	Assistant surgeon when qualified resident not available	Use when assistant surgeon billing is appropriate for a related procedure.
`JW`	Drug discarded/not administered to any patient	Use when a portion of the cosyntropin vial is discarded and must be reported per payer rules.
`JZ`	No drug or biological administration—no service performed	Use if the drug was ordered but not administered.
`QK`	Qualified nonphysician anesthetist service with medical direction by physician	Use only when an anesthesia professional is involved and meets criteria.
`QX`	Rendering practitioner in an APG/CLIA arrangement	Use when a certified practitioner performs the service under a qualified arrangement.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Endocrinology, Diabetes & Metabolism	Endocrinologists commonly order and interpret ACTH stimulation testing.
`363A00000X`	Hospitalist	Hospitalists frequently coordinate testing for inpatients with suspected adrenal insufficiency.
`208D00000X`	Emergency Medicine	Emergency clinicians may order the test for undifferentiated hypotension or shock evaluation.
`364S00000X`	Nursing — Registered Nurse	RNs commonly administer the injection and obtain timed blood draws in clinic or ED.
`261QM0800X`	Family Medicine	Primary care physicians may initiate testing and manage follow-up care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E27.1`	Primary adrenocortical insufficiency (Addison disease)	Cosyntropin stimulation testing helps confirm adrenal cortical insufficiency by assessing cortisol response.
`E27.3`	Drug-induced adrenocortical insufficiency	Used when chronic glucocorticoid therapy or other drugs are suspected to suppress the HPA axis; testing assesses recovery.
`E23.0`	Hypopituitarism	Secondary adrenal insufficiency from pituitary dysfunction is evaluated with ACTH stimulation testing.
`R55`	Syncope and collapse	When unexplained hypotension or syncope prompts assessment for adrenal insufficiency.
`I95.1`	Orthostatic hypotension	Used when orthostatic symptoms raise concern for adrenal insufficiency contributing to blood pressure instability.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used when billing for the administration of an injectable like cosyntropin in an outpatient setting.
`36415`	Collection of venous blood by venipuncture	Used to bill for baseline and timed post‑cosyntropin serum cortisol draws.
`84439`	Assay of cortisol (serum)	Laboratory CPT for measurement of serum cortisol levels obtained during ACTH stimulation testing.
`83001`	Drug screen, qualitative; immunoassay (if applicable)	Occasionally used for ancillary testing in differential diagnosis when toxicologic causes are investigated.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity	Common E/M code for pre‑test evaluation or post‑test result discussion when billed separately from the injection.